Bibliography
- Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR: Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 302(18), 2001–2007 (2009).
- Shaffer EA: Gallstone disease: epidemiology of gallbladder stone disease. Best Pract. Res. Clin. Gastroenterol. 20(6), 981–996 (2006).
- Chapman BA, Burt MJ, Chisholm RJ, Allan RB, Yeo KH, Ross AG: Dissolution of gallstones iwth simvastatin, an HMG CoA reductase inhibitor. Dig. Dis. Sci. 43(2), 349–353 (1998).
- Porsch-Ozcürümez M, Hardt PD, Schnell-Kretschmer H et al.: Effect of fluvustatin on binary lipids in subjects with an elevated cholesterol saturation index. Eur. J. Clin. Pharmacol. 56(12), 873–978 (2001).
- Smith JL, Roach PD, Wittenberg LN et al.: Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones. J. Gastroenterol. Hepatol. 15(8), 871–879 (2001).
- Wilson IR, Hurrell MA, Pattinson NR, Chapman BA: The effect of simvastatin and bezafibrate on bile composition and gall-bladder emptying in female non-insulindependent diabetics. J. Gastroenterol. Hepatol. 9(5), 447–451 (1994).
- Miettinen TE, Kiviluoto T, Taavitsainen M, Vuoristo M, Miettinen TA: Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 27(3), 649–655 (1998).
- Sharma BC, Agarwal DK, Baijal SS, Saraswat VA: Pravastatin has no effect on bile lipid composition, nucleation time, and gallbladder motility in persons with normal levels of cholesterol. J. Clin. Gastroenterol. 25(2), 433–436 (1997).
- Smit JW, van Erpecum KJ, Renooij W et al.: The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease. Hepatology 21(6), 1523–1529 (1995).
- Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Statin use and the risk of cholecystectomy in women. Gastroenterology 136(5), 1593–1600 (2009).
- Simon JA, Hunninghake DB, Agarwal SK et al.: Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/Progestin Replacement Study. Ann. Intern. Med. 135(7), 493–501 (2001).
- Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Statin use and the risk of cholecystectomy in women. Gastroenterology 136(5), 1593–1600 (2009).
- Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL: Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann. Surg. 247(1), 95–103 (2008).